Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
Jan‐Michel Heger, Julia Mattlener, Jessica Schneider, et al.
Blood (2023) Vol. 143, Iss. 6, pp. 522-534
Closed Access | Times Cited: 19

Showing 19 citing articles:

Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma
Mihir Gupta, Joseph D. Bradley, Elie Massaad, et al.
Blood (2024) Vol. 144, Iss. 10, pp. 1093-1100
Open Access | Times Cited: 7
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10
Teresa Calimeri, Nicoletta Anzalone, Maria Giulia Cangi, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 7, pp. e540-e549
Closed Access | Times Cited: 6
Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma
Julia Wendler, Richard Lewis, Alexandra Kutilina, et al.
Haematologica (2025)
Open Access
Stellenwert der Hochdosischemotherapie bei der Therapie primärer Lymphome des zentralen Nervensystems
Gerald Illerhaus, Jan‐Michel Heger
Deleted Journal (2025)
Closed Access
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience
Steven R. Hwang, Richard C. Godby, Brianna J. Gysbers, et al.
Blood Advances (2025) Vol. 9, Iss. 4, pp. 924-932
Open Access
Circulating tumor DNA in lymphoma: technologies and applications
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature
Manabu Natsumeda, Satoshi Shibuma, Haruhiko Takahashi, et al.
Brain Tumor Pathology (2024) Vol. 41, Iss. 2, pp. 85-91
Closed Access | Times Cited: 3
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
Jin‐Hua Liang, Yifan Wu, Hao-Rui Shen, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1541-1552
Closed Access | Times Cited: 3
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
Jan‐Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 35, pp. 4218-4230
Closed Access | Times Cited: 3
Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR
Jan‐Michel Heger, Yannick d’Hargues, Fanni Kleinert, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 6, pp. 957-963
Open Access | Times Cited: 2
Histopathological Diagnosis of Primary Central Nervous System Lymphoma after Therapy with Corticosteroids or Anticoagulants
Julia J. Feldheim, Marvin Darkwah Oppong, Jonas Feldheim, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1157-1157
Open Access | Times Cited: 2
Prospects for liquid biopsy approaches in lymphomas
Esraa Jamal, Edward Poynton, Mohamed Elbogdady, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-11
Open Access | Times Cited: 2
Blood and cerebrospinal fluid biomarkers in neuro-oncology
Roberta Rudà, Alessia Pellerino, Riccardo Soffietti
Current Opinion in Neurology (2024)
Closed Access | Times Cited: 2
Predicting outcomes in CNS lymphoma with ctDNA
Jane N. Winter, Andrés J.M. Ferreri
Blood (2024) Vol. 143, Iss. 6, pp. 478-480
Closed Access | Times Cited: 1
Histopathological Diagnosis of Primary Central Nervous System Lymphoma After Preoperative Corticosteroid Therapy
Julia J. Feldheim, Marvin Darkwah Oppong, Jonas Feldheim, et al.
(2024)
Open Access | Times Cited: 1
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration
Fabian Frontzek, Loïc Renaud, Ulrich Dührsen, et al.
Leukemia (2024) Vol. 38, Iss. 10, pp. 2225-2234
Closed Access | Times Cited: 1
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance
Sijun Zhang, Xiangyu Wang, Zhen-Zhen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future
Junying Li, Li-ping Zuo, Jian Xu, et al.
Blood Reviews (2024), pp. 101237-101237
Closed Access
Biopsy-free diagnosis of primary diffuse large B-cell lymphoma of the central nervous system
Д. А. Королева, Е. Е. Звонков, O. Shchetsova, et al.
Russian journal of hematology and transfusiology (2024) Vol. 69, Iss. 3, pp. 368-383
Open Access
Digital PCR-based quantification of miR-181a in the cerebrospinal fluid aids patient stratification in pediatric acute lymphoblastic leukemia
Borbála Péterffy, Tamás J. Nádasi, Szilvia Krizsán, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top